Meizhi Lu

441 total citations · 1 hit paper
7 papers, 315 citations indexed

About

Meizhi Lu is a scholar working on Nephrology, Molecular Biology and Immunology. According to data from OpenAlex, Meizhi Lu has authored 7 papers receiving a total of 315 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Nephrology, 4 papers in Molecular Biology and 3 papers in Immunology. Recurrent topics in Meizhi Lu's work include Chronic Kidney Disease and Diabetes (3 papers), Parathyroid Disorders and Treatments (2 papers) and RNA modifications and cancer (1 paper). Meizhi Lu is often cited by papers focused on Chronic Kidney Disease and Diabetes (3 papers), Parathyroid Disorders and Treatments (2 papers) and RNA modifications and cancer (1 paper). Meizhi Lu collaborates with scholars based in China and United States. Meizhi Lu's co-authors include Lili Zhou, Youhua Liu, Qian Yuan, Haiyan Fu, Fan Fan Hou, Li Li, Fan Fan Hou, Hongyan Li, Jing Nie and Jinhua Miao and has published in prestigious journals such as Nature Communications, Kidney International and Cell Death and Disease.

In The Last Decade

Meizhi Lu

7 papers receiving 315 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Klotho-derived peptide protects against kidney fibrosis by targeting TGF-β signaling

2022 101 citations Qian Yuan, Qian Ren et al. Nature Communications profile →

Peers

Countries citing papers authored by Meizhi Lu

Since Specialization

Citations

This map shows the geographic impact of Meizhi Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meizhi Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meizhi Lu more than expected).

Fields of papers citing papers by Meizhi Lu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meizhi Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meizhi Lu. The network helps show where Meizhi Lu may publish in the future.

Co-authorship network of co-authors of Meizhi Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Meizhi Lu. A scholar is included among the top collaborators of Meizhi Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meizhi Lu. Meizhi Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

#	Work	Indexed citations
1	FAM210B activates STAT1/IRF9/IFIT3 axis by upregulating IFN-α/β expression to impede the progression of lung adenocarcinoma 2025 ·Cell Death and Disease ·Xuejuan Gao, (unknown), Ying Liu, (unknown), Xiaofen Zheng, (unknown), (unknown), (unknown), (unknown), Zonghua Liu, (unknown), (unknown), Jingjie Jin, Xingfeng Yin, (unknown), (unknown), Meizhi Lu, Gong Zhang, (unknown), Langxia Liu	3
2	Exosomal PPARγ derived from macrophages suppresses LPS-induced peritonitis by negative regulation of CD14/TLR4 axis 2023 ·Inflammation Research ·Meng Meng, Meizhi Lu, Junxia Feng, Xiaoying Zhou, Ping Meng, (unknown), (unknown), Xiaohui Liu, Langxia Liu, Xuejuan Gao, Yunfang Zhang	2
3	Oxidatively stressed extracellular microenvironment drives fibroblast activation and kidney fibrosis 2023 ·Redox Biology ·Li Li, Meizhi Lu, (unknown), Junxin Huang, (unknown), Jian Chen, Jing Li, Xue Hong, Meizhi He, Haiyan Fu, Ruiyuan Liu, Fan Fan Hou, Lili Zhou, Youhua Liu	50
4	A Klotho-derived peptide protects against kidney fibrosis by targeting TGF-β signaling breakdown → 2022 ·Nature Communications ·Qian Yuan, Qian Ren, Li Li, Huishi Tan, Meizhi Lu, Yuan Tian, (unknown), Boxin Zhao, Haiyan Fu, Fan Fan Hou, Lili Zhou, Youhua Liu	101
5	PPARγ alleviates peritoneal fibrosis progression along with promoting GLUT1 expression and suppressing peritoneal mesothelial cell proliferation 2022 ·Molecular and Cellular Biochemistry ·Junxia Feng, Meizhi Lu, Wenhao Li, Jingchun Li, Ping Meng, (unknown), Xuejuan Gao, (unknown)	8
6	Screening of the Key Genes and Signalling Pathways for Diabetic Nephropathy Using Bioinformatics Analysis 2022 ·Frontiers in Endocrinology ·(unknown), Junxia Feng, (unknown), Meizhi Lu, Xuejuan Gao, (unknown)	23
7	Wnt/β-catenin links oxidative stress to podocyte injury and proteinuria 2019 ·Kidney International ·Lili Zhou, Xiaowen Chen, Meizhi Lu, Qinyu Wu, Qian Yuan, (unknown), Jinhua Miao, Yunfang Zhang, Hongyan Li, Fan Fan Hou, Jing Nie, Youhua Liu	128

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact